INmune Bio Inc. is a clinical-stage biotechnology company focused on developing immunotherapies to treat cancer and neurodegenerative diseases. The company’s innovative platforms aim to harness the power of the immune system to target and eliminate harmful cells, while preserving healthy cells. With a strong pipeline and cutting-edge technology, INmune Bio Inc. is poised to make a meaningful impact in the field of immunotherapy.
